One recent randomized trial demonstrated significant improvements in HbA1c and average glucose levels for people with type 1 diabetes (PWT1D) with HbA1c levels greater than 8.0% (64 mmol/mL) compared to a group using multiple daily insulin injections plus CGM [1]. The gene discussed is INS; the disease is type 1 diabetes mellitus.